135 related articles for article (PubMed ID: 6175774)
1. Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infection.
Smith CI; Kitchen LW; Scullard GH; Robinson WS; Gregory PB; Merigan TC
JAMA; 1982 Apr; 247(16):2261-5. PubMed ID: 6175774
[TBL] [Abstract][Full Text] [Related]
2. Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. A randomized, double-blinded, placebo-controlled trial.
Garcia G; Smith CI; Weissberg JI; Eisenberg M; Bissett J; Nair PV; Mastre B; Rosno S; Roskamp D; Waterman K
Ann Intern Med; 1987 Sep; 107(3):278-85. PubMed ID: 2441633
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis.
Hoofnagle JH; Hanson RG; Minuk GY; Pappas SC; Schafer DF; Dusheiko GM; Straus SE; Popper H; Jones EA
Gastroenterology; 1984 Jan; 86(1):150-7. PubMed ID: 6196251
[TBL] [Abstract][Full Text] [Related]
4. A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication.
Lok AS; Novick DM; Karayiannis P; Dunk AA; Sherlock S; Thomas HC
Hepatology; 1985; 5(6):1132-8. PubMed ID: 2415436
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of ARA-AMP on serum DNA polymerase activity and serum HBV-DNA in chronic hepatitis B virus infection. A possible reason for lack of efficacy.
Alexander GJ; Fagan EA; Rolando N; Guarner P; Callender ME; Eddleston AL; Williams R
J Hepatol; 1986; 3 Suppl 2():S81-6. PubMed ID: 2439580
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).
Weller IV; Bassendine MF; Craxi A; Fowler MJ; Monjardino J; Thomas HC; Sherlock S
Gut; 1982 Sep; 23(9):717-23. PubMed ID: 6179819
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled trial of adenine arabinoside 5'-monophosphate in chronic active hepatitis B: comparison of the efficacy in heterosexual and homosexual patients.
Marcellin P; Ouzan D; Degos F; Brechot C; Metman EH; Degott C; Chevalier M; Berthelot P; Trepo C; Benhamou JP
Hepatology; 1989 Sep; 10(3):328-31. PubMed ID: 2474480
[TBL] [Abstract][Full Text] [Related]
8. Interferon vs. adenine arabinoside 5'-monophosphate in patients with anti-HBe-positive chronic hepatitis.
Buti M; Jardi R; Rodriguez-Frias F; Allende H; Cotrina M; Esteban R; Guardia J
J Med Virol; 1996 Aug; 49(4):325-8. PubMed ID: 8877766
[TBL] [Abstract][Full Text] [Related]
9. Histological improvement after anti-viral treatment for chronic hepatitis B virus infection.
Brook MG; Petrovic L; McDonald JA; Scheuer PJ; Thomas HC
J Hepatol; 1989 Mar; 8(2):218-25. PubMed ID: 2469711
[TBL] [Abstract][Full Text] [Related]
10. Treatment of the chronic hepatitis B virus carrier state.
Lever AM
J Infect; 1988 May; 16(3):221-9. PubMed ID: 2456355
[TBL] [Abstract][Full Text] [Related]
11. A randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.
Weller IV
J Hepatol; 1986; 3 Suppl 2():S107-10. PubMed ID: 2439568
[TBL] [Abstract][Full Text] [Related]
12. Adenine arabinoside 5'-monophosphate treatment of chronic type B hepatitis.
Hoofnagle JH; Minuk GY; Dusheiko GM; Schafer DF; Johnson R; Straus S; Jones EA; Gerin JL; Ishak K
Hepatology; 1982; 2(6):784-8. PubMed ID: 6183183
[TBL] [Abstract][Full Text] [Related]
13. Antiviral treatment in chronic hepatitis B. Data of 5 prospectively controlled randomized trials.
Müller R; Klein H; Vido I; Niehoff G; Lautz HU; Gebel M; Schmidt FW
J Hepatol; 1986; 3 Suppl 2():S217-23. PubMed ID: 2439573
[No Abstract] [Full Text] [Related]
14. Identification of factors influencing response rate to antiviral therapy of chronic hepatitis B virus infection. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies.
Scully LJ; Lever AM; Yap I; Pignatelli M; Thomas HC
J Hepatol; 1986; 3 Suppl 2():S291-9. PubMed ID: 2439575
[TBL] [Abstract][Full Text] [Related]
15. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.
Bassendine MF; Chadwick RG; Salmeron J; Shipton U; Thomas HC; Sherlock S
Gastroenterology; 1981 May; 80(5 pt 1):1016-22. PubMed ID: 7009310
[TBL] [Abstract][Full Text] [Related]
16. The use of corticosteroids in conjunction with antiviral therapy in chronic hepatitis B with ongoing viral replication.
Perrillo RP
J Hepatol; 1986; 3 Suppl 2():S57-64. PubMed ID: 2439577
[TBL] [Abstract][Full Text] [Related]
17. Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside.
Scullard GH; Pollard RB; Smith JL; Sacks SL; Gregory PB; Robinson WS; Merigan TC
J Infect Dis; 1981 Jun; 143(6):772-83. PubMed ID: 6166691
[TBL] [Abstract][Full Text] [Related]
18. Acute delta hepatitis during treatment with adenosine arabinoside monophosphate with resolution of the HBsAg carrier state.
Garcia G; Smedile A; Bergmann KF; Gerin JL; Gregory PB; Merigan TC; Robinson WS
West J Med; 1990 Jul; 153(1):80-2. PubMed ID: 1697132
[No Abstract] [Full Text] [Related]
19. Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.
Weller IV; Lok AS; Mindel A; Karayiannis P; Galpin S; Monjardino J; Sherlock S; Thomas HC
Gut; 1985 Jul; 26(7):745-51. PubMed ID: 2410328
[TBL] [Abstract][Full Text] [Related]
20. Antiviral treatment of chronic hepatitis B virus infection: improvement in liver disease with interferon and adenine arabinoside.
Scullard GH; Andres LL; Greenberg HB; Smith JL; Sawhney VK; Neal EA; Mahal AS; Popper H; Merigan TC; Robinson WS; Gregory PB
Hepatology; 1981; 1(3):228-32. PubMed ID: 6169615
[No Abstract] [Full Text] [Related]
[Next] [New Search]
